As of Aug 27
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 158.00, with a high estimate of 200.00 and a low estimate of 136.00. The median estimate represents a +6.10% increase from the last price of 148.92.
The current consensus among 4 polled investment analysts is to Hold stock in USANA Health Sciences Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.